NEXT Financial Group, Inc - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 84 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q4 2021$2,0000.0%4750.0%0.00%
Q3 2021$2,0000.0%4750.0%0.00%
Q2 2021$2,000
-33.3%
4750.0%0.00%
Q1 2021$3,0000.0%4750.0%0.00%
Q4 2020$3,000
-25.0%
4750.0%0.00%
Q3 2020$4,000
+300.0%
4750.0%0.00%
Q1 2020$1,0000.0%4750.0%0.00%
Q4 2019$1,0000.0%4750.0%0.00%
Q3 2019$1,000
-50.0%
4750.0%0.00%
Q2 2019$2,0000.0%4750.0%0.00%
-100.0%
Q1 2019$2,000
-33.3%
4750.0%0.00%0.0%
Q4 2018$3,000
-50.0%
4750.0%0.00%
-66.7%
Q3 2018$6,0004750.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 5,555,461$5,416,5742.98%
NEA Management Company, LLC 17,079,778$16,651,0761.25%
EcoR1 Capital, LLC 27,404,070$26,716,2280.82%
MPM BioImpact LLC 5,095,912$4,968,5140.77%
PFM Health Sciences, LP 10,520,231$10,256,1730.51%
Long Focus Capital Management, LLC 12,346,417$12,036,5220.46%
Matrix Capital Management Company, LP 38,974,185$37,995,9330.29%
Acuitas Investments, LLC 541,201$527,6170.28%
TANG CAPITAL MANAGEMENT LLC 1,743,619$1,699,8540.17%
Key Client Fiduciary Advisors, LLC 263,989$257,3630.13%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders